Picture courtesy Twitter
New Delhi: The Drug Controller General of India (DCGI) is likely to allow the emergency use of the Covishield vaccine in India without the necessary approval from the UK where it was developed, according to two senior government officials in the know of the matter.
If the clinical data furnished by the Serum Institute is found satisfactory, the DCGI may clear the shot for use, the officials said on the condition of anonymity.
“Serum Institute has submitted the additional data as sought by the subject expert committee in the last review (on 9 December),” one of the officials was quoted as saying by Mint.
Covishield — Serum Institute’s version of the vaccine — is being developed by Oxford University and British drugmaker AstraZeneca Plc. The expert panel had asked the Serum Institute in the December meeting to present the result of the assessment of the UK regulator for granting emergency use licence.
Bargarh: A new artist will be selected to play the mythological character King Kansa during…
Mumbai: Suhana Khan will be making her Bollywood debut with ‘King’ along with her superstar…
New Delhi: After Diljit Dosanjh called out the double standards of Telangana government for banning…
New Delhi: Recent actions and counter-actions in the Russia-Ukraine conflict have pushed the world to the…
Balangir: Three persons were arrested and fake IPS officers’ uniforms along with fake identity cards…
Mumbai: Abhishek Bachchan’s highly-anticipated film ‘I Want To Talk’ released in theatres on Friday, and the…
New Delhi: Accused of giving cash to secure votes ahead of election day in Maharashtra,…
Bhubaneswar: Chief Minister Mohan Charan Majhi attended the ‘Odisha State Day Celebrations’ at the 43rd…